Skip to main content
ABUS logo
ABUS
(NASDAQ)
Arbutus Biopharma Corporation
$4.46-- (--)
Loading... - Market loading

Arbutus Biopharma (ABUS) Stock Price & Financial Analysis

Arbutus Biopharma Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.46 - $4.60
52-Week High$5.10
52-Week Low$2.71
Open$4.47
Volume696.17K
Average Volume (3M)696.17K
Market Cap859.17M
Shares Outstanding191.78M
Price to Sales (P/S)59.35
Price to Book (P/B)11.20
EV/EBITDA-20.38
Revenue (TTM)14.08M
Net Income (TTM)-33.50M
Free Cash Flow (TTM)-45.35M
EPS (TTM)$-0.22
Profit Margin-289.45%
Operating Margin-214.67%
Return on Equity (ROE)-54.62%
Debt to Equity0.01
50-Day MA$4.32
200-Day MA$4.14
52-Week Change29.89%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Arbutus Biopharma

What is the current stock price for ABUS?

As of the latest trading session, ABUS stock trades at $4.46. The 52-week range is $2.71–$5.10, with a day range of $4.46–$4.60.

What is the P/E ratio for ABUS?

The P/E ratio (Price-to-Earnings) for ABUS is shown in the Key Statistics section. This valuation metric helps compare Arbutus Biopharma Corporation to industry peers.

Does ABUS pay dividends?

Arbutus Biopharma does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ABUS?

Analyst ratings and recommendations for ABUS are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of ABUS?

Arbutus Biopharma's market capitalization is $855.3M, classifying it as a small-cap company. Arbutus Biopharma operates in the Healthcare sector within the Biotechnology industry.